Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada

Imported GMP API across Canadian-US Border Establishes supply chain ­stability in Canada and large US pharmaceutical market VANCOUVER, BC, June 9, 2023 /PRNewswire/ – Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with clinically proven psilocybin treatments, announces Health Canada Approval of the company’s secondary US-based supplier of Good Manufacturing Practices … Read more